{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T06:38:23Z","timestamp":1789799903585,"version":"4.0.1"},"reference-count":78,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,8]],"date-time":"2024-01-08T00:00:00Z","timestamp":1704672000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.autrev.2023.103511","type":"journal-article","created":{"date-parts":[[2023,12,31]],"date-time":"2023-12-31T09:56:29Z","timestamp":1704016589000},"page":"103511","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Benign prostatic hyperplasia - A novel autoimmune disease with a potential therapy consequence?"],"prefix":"10.1016","volume":"23","author":[{"given":"Victoria","family":"Liedtke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"St\u00f6ckle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerstin","family":"Junker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Roggenbuck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2023.103511_bb0005","first-page":"S122","article-title":"BPH: epidemiology and comorbidities","volume":"12","author":"McVary","year":"2006","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.autrev.2023.103511_bb0010","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.ucl.2016.04.001","article-title":"The epidemiology of benign prostatic hyperplasia associated with lower urinary tract symptoms","volume":"43","author":"Egan","year":"2016","journal-title":"Urol Clin North Am"},{"key":"10.1016\/j.autrev.2023.103511_bb0015","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1038\/s41467-022-29719-1","article-title":"TNF is a potential therapeutic target to suppress prostatic inflammation and hyperplasia in autoimmune disease","volume":"13","author":"Vickman","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.autrev.2023.103511_bb0020","author":"Surgery - Urology Care Foundation"},{"key":"10.1016\/j.autrev.2023.103511_bb0025","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0022-5347(17)71941-6","article-title":"Inflammation of the prostate gland","volume":"38","author":"Moore","year":"1937","journal-title":"J Urol"},{"key":"10.1016\/j.autrev.2023.103511_bb0030","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1016\/S0022-5347(01)63564-X","article-title":"How common is prostatitis? A national survey of physician visits","volume":"159","author":"Collins","year":"1998","journal-title":"J Urol"},{"key":"10.1016\/j.autrev.2023.103511_bb0035","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.urology.2007.11.155","article-title":"Longitudinal association between prostatitis and development of benign prostatic hyperplasia","volume":"71","author":"St. Sauver","year":"2008","journal-title":"Urology"},{"key":"10.1016\/j.autrev.2023.103511_bb0040","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1146\/annurev.med.57.011205.135654","article-title":"Prostatitis\/chronic pelvic pain syndrome","volume":"57","author":"Habermacher","year":"2006","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.autrev.2023.103511_bb0045","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1002\/pros.21027","article-title":"Inflammation in benign prostatic hyperplasia: a 282 patients\u2019 immunohistochemical analysis: BPH and inflammation","volume":"69","author":"Robert","year":"2009","journal-title":"Prostate"},{"key":"10.1016\/j.autrev.2023.103511_bb0050","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/j.eururo.2007.11.026","article-title":"The relationship between prostate inflammation and lower urinary tract symptoms: examination of baseline data from the REDUCE trial","volume":"54","author":"Nickel","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.autrev.2023.103511_bb0055","first-page":"5","article-title":"10 the impact of acute or chronic inflammation in baseline biopsy on the risk of progression in the MTOPS study","volume":"4","author":"Roehrborn","year":"2005","journal-title":"Eur Urol Suppl"},{"key":"10.1016\/j.autrev.2023.103511_bb0060","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/pros.10084","article-title":"Increased expression of lymphocyte-derived cytokines in benign hyperplastic prostate tissue, identification of the producing cell types, and effect of differentially expressed cytokines on stromal cell proliferation","volume":"52","author":"Kramer","year":"2002","journal-title":"Prostate"},{"key":"10.1016\/j.autrev.2023.103511_bb0065","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1097\/01.LAB.0000081388.40145.65","article-title":"Cytokine expression pattern in benign prostatic hyperplasia infiltrating T cells and impact of lymphocytic infiltration on cytokine mRNA profile in prostatic tissue","volume":"83","author":"Steiner","year":"2003","journal-title":"Lab Invest"},{"key":"10.1016\/j.autrev.2023.103511_bb0070","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/MOU.0b013e32835abd4a","article-title":"Correlation between benign prostatic hyperplasia and inflammation","volume":"23","author":"Bostanci","year":"2013","journal-title":"Curr Opin Urol"},{"key":"10.1016\/j.autrev.2023.103511_bb0075","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1007\/s00345-020-03090-6","article-title":"Chronic inflammation promotes proliferation in the prostatic stroma in rats with experimental autoimmune prostatitis: study for a novel method of inducing benign prostatic hyperplasia in a rat model","volume":"38","author":"Zhang","year":"2020","journal-title":"World J Urol"},{"key":"10.1016\/j.autrev.2023.103511_bb0080","first-page":"JCI38332","article-title":"An aberrant prostate antigen\u2013specific immune response causes prostatitis in mice and is associated with chronic prostatitis in humans","author":"Hou","year":"2009","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2023.103511_bb0085","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0302-2838(01)00039-2","volume":"41","author":"Androgen","year":"2002","journal-title":"Eur Urol"},{"key":"10.1016\/j.autrev.2023.103511_bb0090","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0022-5347(17)41924-0","article-title":"The role of androgens and estrogens in the pathogenesis of experimental nonbacterial prostatitis","volume":"140","author":"Naslund","year":"1988","journal-title":"J Urol"},{"key":"10.1016\/j.autrev.2023.103511_bb0095","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/pros.2990120310","article-title":"Sex-hormone-induced inflammation and fibromuscular proliferation in the rat lateral prostate","volume":"12","author":"Lee","year":"1988","journal-title":"Prostate"},{"key":"10.1016\/j.autrev.2023.103511_bb0100","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/sj.pcan.4500391","article-title":"Models for studying benign prostatic hyperplasia","volume":"3","author":"Mahapokai","year":"2000","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.autrev.2023.103511_bb0105","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1365-3083.2007.01971.x","article-title":"Autoimmune prostatitis: state of the art","volume":"66","author":"Motrich","year":"2007","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.autrev.2023.103511_bb0110","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.juro.2008.10.067","article-title":"New histopathological experimental model for benign prostatic hyperplasia: stromal hyperplasia in rats","volume":"181","author":"Mori","year":"2009","journal-title":"J Urol"},{"key":"10.1016\/j.autrev.2023.103511_bb0115","doi-asserted-by":"crossref","first-page":"20357","DOI":"10.1038\/s41598-019-57001-w","article-title":"Complement activation by autoantigen recognition in the growth process of benign prostatic hyperplasia","volume":"9","author":"Hata","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.autrev.2023.103511_bb0120","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0167-5699(95)80089-1","article-title":"Post-thymectomy autoimmunity: abnormal T-cell homeostasis","volume":"16","author":"Bonomo","year":"1995","journal-title":"Immunol Today"},{"key":"10.1016\/j.autrev.2023.103511_bb0125","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1093\/intimm\/dxf105","article-title":"Differential effect of neonatal thymectomy on systemic and organ-specific autoimmune disease","volume":"14","author":"Bagavant","year":"2002","journal-title":"Int Immunol"},{"key":"10.1016\/j.autrev.2023.103511_bb0130","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1586\/eci.09.37","article-title":"Prostate autoimmunity: from experimental models to clinical counterparts","volume":"5","author":"Penna","year":"2009","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.autrev.2023.103511_bb0135","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1080\/01485010600908397","article-title":"Increased inflammatory factors activity in model rats with experimental autoimmune prostatitis","volume":"53","author":"Zhou","year":"2007","journal-title":"Arch Androl"},{"key":"10.1016\/j.autrev.2023.103511_bb0140","first-page":"96","article-title":"Phenotypic characterization of infiltrating leukocytes in benign prostatic hyperplasia","volume":"66","author":"Theyer","year":"1992","journal-title":"Lab Investig J Tech Methods Pathol"},{"key":"10.1016\/j.autrev.2023.103511_bb0145","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0090-4295(97)00456-1","article-title":"Autoimmune prostatitis: evidence of T cell reactivity with normal prostatic proteins","volume":"50","author":"Alexander","year":"1997","journal-title":"Urology"},{"key":"10.1016\/j.autrev.2023.103511_bb0150","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/S0090-4295(98)00390-2","article-title":"Elevated levels of proinflammatory cytokines in the semen of patients with chronic prostatitis\/chronic pelvic pain syndrome","volume":"52","author":"Alexander","year":"1998","journal-title":"Urology"},{"key":"10.1016\/j.autrev.2023.103511_bb0155","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/1097-0045(20000615)44:1<49::AID-PROS7>3.0.CO;2-7","article-title":"PSA is a candidate self-antigen in autoimmune chronic prostatitis\/chronic pelvic pain syndrome","volume":"44","author":"Ponniah","year":"2000","journal-title":"Prostate"},{"key":"10.1016\/j.autrev.2023.103511_bb0160","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/00002371-200403000-00007","article-title":"CD4 and CD8 T-lymphocyte recognition of prostate specific antigen in granulomatous prostatitis","volume":"27","author":"Klyushnenkova","year":"2004","journal-title":"J Immunother"},{"key":"10.1016\/j.autrev.2023.103511_bb0165","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1046\/j.1365-2249.2002.01853.x","article-title":"Autoimmune T cell responses to seminal plasma in chronic pelvic pain syndrome (CPPS)","volume":"128","author":"Batstone","year":"2002","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2023.103511_bb0170","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1159\/000052415","article-title":"Noninflammatory chronic pelvic pain syndrome: immunological study in blood, ejaculate and prostate Tissue1","volume":"39","author":"John","year":"2001","journal-title":"Eur Urol"},{"key":"10.1016\/j.autrev.2023.103511_bb0175","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0022-5347(05)64916-6","article-title":"Cytokine polymorphisms in men with chronic prostatitis\/chronic pelvic pain syndrome: association with diagnosis and treatment response","volume":"168","author":"Shoskes","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.autrev.2023.103511_bb0180","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.clim.2005.03.011","article-title":"Presence of INF\u03b3-secreting lymphocytes specific to prostate antigens in a group of chronic prostatitis patients","volume":"116","author":"Motrich","year":"2005","journal-title":"Clin Immunol"},{"key":"10.1016\/j.autrev.2023.103511_bb0185","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1111\/j.1464-410X.2006.06133.x","article-title":"Interleukin-8 levels in seminal plasma in chronic prostatitis\/chronic pelvic pain syndrome and nonspecific urethritis","volume":"97","author":"Khadra","year":"2006","journal-title":"BJU Int"},{"key":"10.1016\/j.autrev.2023.103511_bb0190","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1046\/j.1442-2042.2001.00358.x","article-title":"Seminal plasma cytokine levels in the diagnosis of chronic pelvic pain syndrome","volume":"8","author":"Orhan","year":"2008","journal-title":"Int J Urol"},{"key":"10.1016\/j.autrev.2023.103511_bb0195","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1016\/j.juro.2009.07.067","article-title":"T-cell recognition of prostatic peptides in men with chronic prostatitis\/chronic pelvic pain syndrome","volume":"182","author":"Kouiavskaia","year":"2009","journal-title":"J Urol"},{"key":"10.1016\/j.autrev.2023.103511_bb0200","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s00005-021-00628-3","article-title":"Chronic prostatitis and pelvic pain syndrome: another autoimmune disease?","volume":"69","author":"Chen","year":"2021","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"10.1016\/j.autrev.2023.103511_bb0205","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1111\/j.1464-410X.1990.tb14827.x","article-title":"Intraprostatic antibody deposition in chronic Abacterial prostatitis","volume":"65","author":"Doble","year":"1990","journal-title":"Br J Urol"},{"key":"10.1016\/j.autrev.2023.103511_bb0210","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/j.1439-0272.2003.tb00860.x","article-title":"Immunological alterations in the ejaculate of chronic prostatitis patients: clues for autoimmunity","volume":"35","author":"John","year":"2003","journal-title":"Andrologia"},{"key":"10.1016\/j.autrev.2023.103511_bb0215","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/S0022-5347(01)66974-X","article-title":"Autoantibodies to prostate specific antigen in patients with benign prostatic hyperplasia","volume":"154","author":"Zisman","year":"1995","journal-title":"J Urol"},{"key":"10.1016\/j.autrev.2023.103511_bb0220","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/and.12265","article-title":"Presence of PSA auto-antibodies in men with prostate abnormalities (prostate cancer\/benign prostatic hyperplasia\/prostatitis)","volume":"47","author":"Lokant","year":"2015","journal-title":"Andrologia"},{"key":"10.1016\/j.autrev.2023.103511_bb0225","first-page":"79","article-title":"Prostate cancer autoantibodies - applications in diagnosis, prognosis, monitoring disease progression and immunotherapy","volume":"11","author":"Jayakrishnan","year":"2023","journal-title":"Am J Clin Exp Urol"},{"key":"10.1016\/j.autrev.2023.103511_bb0230","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1023\/B:JOCI.0000040920.96065.5a","article-title":"Identification of antigen-specific IgG in sera from patients with chronic prostatitis","volume":"24","author":"Dunphy","year":"2004","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.autrev.2023.103511_bb0235","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1002\/pros.21229","article-title":"Antibody responses to prostate-associated antigens in patients with prostatitis and prostate cancer: antibodies to prostate-associated antigens","volume":"71","author":"Maricque","year":"2011","journal-title":"Prostate"},{"key":"10.1016\/j.autrev.2023.103511_bb0240","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.cca.2011.11.027","article-title":"Autoantibody signatures as biomarkers to distinguish prostate cancer from benign prostatic hyperplasia in patients with increased serum prostate specific antigen","volume":"413","author":"O\u2019Rourke","year":"2012","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.autrev.2023.103511_bb0245","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1479-5876-9-43","article-title":"A novel multiplex assay combining autoantibodies plus PSA has potential implications for classification of prostate cancer from non-malignant cases","volume":"9","author":"Xie","year":"2011","journal-title":"J Transl Med"},{"key":"10.1016\/j.autrev.2023.103511_bb0250","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0128235","article-title":"Combination of autoantibody signature with PSA level enables a highly accurate blood-based differentiation of prostate Cancer patients from patients with benign prostatic hyperplasia","volume":"10","author":"Leidinger","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/j.autrev.2023.103511_bb0255","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1002\/pros.23684","article-title":"Identification and preliminary study of immunogens involved in autoimmune prostatitis in human males","volume":"78","author":"Lu","year":"2018","journal-title":"Prostate"},{"key":"10.1016\/j.autrev.2023.103511_bb0260","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/pros.23284","article-title":"Autoantibodies directed against the endothelin a receptor in patients with benign prostatic hyperplasia: prostate and endothelin receptor autoantibodies","volume":"77","author":"Wallukat","year":"2017","journal-title":"Prostate"},{"key":"10.1016\/j.autrev.2023.103511_bb0265","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s00281-014-0425-9","article-title":"Agonistic autoantibodies directed against G-protein-coupled receptors and their relationship to cardiovascular diseases","volume":"36","author":"Wallukat","year":"2014","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.autrev.2023.103511_bb0270","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1093\/eurjhf\/hfs123","article-title":"Long-term benefits of immunoadsorption in \u03b2 1 -adrenoceptor autoantibody-positive transplant candidates with dilated cardiomyopathy","volume":"14","author":"Dandel","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.autrev.2023.103511_bb0275","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13317-020-00136-y","article-title":"Autoantibodies directed against \u03b11-adrenergic receptor and endothelin receptor a in patients with prostate cancer","volume":"11","author":"Wallukat","year":"2020","journal-title":"Autoimmun Highlights"},{"key":"10.1016\/j.autrev.2023.103511_bb0280","doi-asserted-by":"crossref","first-page":"6166","DOI":"10.3390\/ijms24076166","article-title":"Over-expression of LEDGF\/p75 in HEp-2 cells enhances autoimmune IgG response in patients with benign prostatic hyperplasia\u2014a novel diagnostic approach with therapeutic consequence?","volume":"24","author":"Liedtke","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.autrev.2023.103511_bb0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2020.108349","article-title":"The binding of SLE autoantibodies to mitochondria","volume":"212","author":"Pisetsky","year":"2020","journal-title":"Clin Immunol"},{"key":"10.1016\/j.autrev.2023.103511_bb0290","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1084\/jem.20151876","article-title":"Oxidized mitochondrial nucleoids released by neutrophils drive type I interferon production in human lupus","volume":"213","author":"Caielli","year":"2016","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2023.103511_bb0295","doi-asserted-by":"crossref","first-page":"3190","DOI":"10.1002\/art.39296","article-title":"Neutrophil extracellular trap mitochondrial DNA and its autoantibody in systemic lupus erythematosus and a proof-of-concept trial of Metformin: NET mtDNA AND METFORMIN IN SLE","volume":"67","author":"Wang","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2023.103511_bb0300","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.tibs.2014.12.001","article-title":"Host factors for retroviral integration site selection","volume":"40","author":"Debyser","year":"2015","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.autrev.2023.103511_bb0305","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003957","article-title":"Oncogenic human papillomaviruses activate the tumor-associated Lens epithelial-derived growth factor (LEDGF) gene","volume":"10","author":"Leitz","year":"2014","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.autrev.2023.103511_bb0310","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13317-020-0126-4","article-title":"Twenty years of research on the DFS70\/LEDGF autoantibody-autoantigen system: many lessons learned but still many questions","volume":"11","author":"Ortiz-Hernandez","year":"2020","journal-title":"Autoimmun Highlights"},{"key":"10.1016\/j.autrev.2023.103511_bb0315","first-page":"6","article-title":"DFS70\/LEDGFp75: an enigmatic autoantigen at the Interface between autoimmunity, AIDS, and Cancer","author":"Basu","year":"2015","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2023.103511_bb0320","series-title":"HIV Interact. Host Cell Proteins","first-page":"125","article-title":"Virological and cellular roles of the transcriptional coactivator LEDGF\/p75","volume":"vol. 339","author":"Llano","year":"2009"},{"key":"10.1016\/j.autrev.2023.103511_bb0325","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/S1568-9972(03)00063-6","article-title":"LEDGF\/p75: a novel nuclear autoantigen at the crossroads of cell survival and apoptosis","volume":"2","author":"Ganapathy","year":"2003","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2023.103511_bb0330","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S1350-9462(02)00007-1","article-title":"LEDGF, a survival factor, activates stress-related genes","volume":"21","author":"Shinohara","year":"2002","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.autrev.2023.103511_bb0335","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0146549","article-title":"LEDGF\/p75 overexpression attenuates oxidative stress-induced necrosis and upregulates the oxidoreductase ERP57\/PDIA3\/GRP58 in prostate Cancer","volume":"11","author":"Basu","year":"2016","journal-title":"PloS One"},{"key":"10.1016\/j.autrev.2023.103511_bb0340","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2021.102869","article-title":"Reactive oxygen species: the yin and Yang in (auto-)immunity","volume":"20","author":"Scherlinger","year":"2021","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2023.103511_bb0345","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1067\/mai.2000.107039","article-title":"Autoantibodies to DFS 70 kd\/transcription coactivator p75 in atopic dermatitis and other conditions","volume":"105","author":"Ochs","year":"2000","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.autrev.2023.103511_bb0350","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.autrev.2011.11.005","article-title":"Importance of the dense fine speckled pattern on HEp-2 cells and anti-DFS70 antibodies for the diagnosis of systemic autoimmune diseases","volume":"11","author":"Mahler","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2023.103511_bb0355","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.autrev.2015.11.006","article-title":"Towards a better understanding of the clinical association of anti-DFS70 autoantibodies","volume":"15","author":"Mahler","year":"2016","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2023.103511_bb0360","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/pros.20112","article-title":"Antinuclear autoantibodies in prostate cancer: immunity to LEDGF\/p75, a survival protein highly expressed in prostate tumors and cleaved during apoptosis","volume":"62","author":"Daniels","year":"2005","journal-title":"Prostate"},{"key":"10.1016\/j.autrev.2023.103511_bb0365","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1158\/1541-7786.MCR-08-0125","article-title":"Alternative splicing and caspase-mediated cleavage generate antagonistic variants of the stress Oncoprotein LEDGF\/p75","volume":"6","author":"Brown-Bryan","year":"2008","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.autrev.2023.103511_bb0370","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1002717","article-title":"Psip1\/Ledgf p52 binds methylated histone H3K36 and splicing factors and contributes to the regulation of alternative splicing","volume":"8","author":"Pradeepa","year":"2012","journal-title":"PLoS Genet"},{"key":"10.1016\/j.autrev.2023.103511_bb0375","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/path.2287","article-title":"TNF-mediated inflammatory disease","volume":"214","author":"Bradley","year":"2008","journal-title":"J Pathol"},{"key":"10.1016\/j.autrev.2023.103511_bb0380","doi-asserted-by":"crossref","first-page":"768","DOI":"10.3390\/ijms19030768","article-title":"Structural biology of the TNF\u03b1 antagonists used in the treatment of rheumatoid arthritis","volume":"19","author":"Lim","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.autrev.2023.103511_bb0385","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1056\/NEJMoa030656","article-title":"The long-term effect of doxazosin, finasteride, and combination Therapy on the clinical progression of benign prostatic hyperplasia","volume":"349","author":"McConnell","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2023.103511_bb0390","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/luts.12423","article-title":"The efficacy and safety of desmopressin acetate applied for nocturia in benign prostatic hyperplasia patients: a systematic review and meta-analysis","volume":"14","author":"Wang","year":"2022","journal-title":"LUTS Low Urin Tract Symptoms"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997223002458?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997223002458?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T02:30:05Z","timestamp":1715049005000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997223002458"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":78,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S1568997223002458"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2023.103511","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Benign prostatic hyperplasia - A novel autoimmune disease with a potential therapy consequence?","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2023.103511","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"103511"}}